Sign in
Saudi Society of Maternal-Fetal Medicine guidance on pregnancy and coronavirus disease 2019
Journal article   Open access  Peer reviewed

Saudi Society of Maternal-Fetal Medicine guidance on pregnancy and coronavirus disease 2019

Yaser A Faden, Nadia A Alghilan, Samiha H Alawami, Eman S Alsulmi, Hythem A Alsum, Yasir A Katib, Yasser S Sabr, Fadwah H Tahir and Nabeel S Bondagji
Saudi medical journal, Vol.41(8), pp.779-790
01/08/2020
PMID: 32789417

Abstract

Anticoagulants - therapeutic use Antiviral Agents - therapeutic use Betacoronavirus Congenital Abnormalities - virology Coronavirus Infections - drug therapy Coronavirus Infections - therapy Coronavirus Infections - transmission COVID-19 COVID-19 Drug Treatment Critical Illness Delivery, Obstetric - methods Female Heparin - therapeutic use Humans Hydroxychloroquine - therapeutic use Infant, Newborn Infectious Disease Transmission, Vertical Magnesium Sulfate - therapeutic use Pandemics Perinatology Personal Protective Equipment Pneumonia, Viral - therapy Pneumonia, Viral - transmission Postnatal Care Pregnancy Pregnancy Complications, Infectious - therapy Pregnancy Outcome Prenatal Care - methods SARS-CoV-2 Saudi Arabia Societies, Medical Thromboembolism - prevention & control Tocolytic Agents - therapeutic use
[No Abstract Available]    Saudi Med J 2020; Vol. 41 (8): 779-790doi: 10.15537/smj.2020.8.25222 How to cite this article:Yaser A. Faden, Nadia A. Alghilan,  Samiha H. Alawami, Eman S. Alsulmi, Hythem A. Alsum, Yasir A. Katib, Yasser S. Sabr, Fadwah H. Tahir, Nabeel S. Bondagji. Saudi Society of Maternal-Fetal Medicine guidance on pregnancy and coronavirus disease 2019. Saudi Med J 2020; Vol. 41 (8): 779-790. doi: 10.15537/smj.2020.8.25222.
url
https://doi.org/10.15537/smj.2020.8.25222View
Published (Version of record) Open

Metrics

1 Record Views

Details